Consumer Affairs
US Congress 115th Congress
Marijuana Revenue and Regulation Act [S.776]
[Cannabis ]
[Finance ]
[Taxes ]
[Alcoholic Beverages ]
[Crime ]
[Consumer Protection ]
[Food ]
[Public Health ]
Marijuana Revenue and Regulation Act This bill removes marijuana from the list of controlled substances and establishes requirements for the taxation and regulation of marijuana products. The bill amends the Internal Revenue Code to impose: (1) an excise tax on any marijuana product produced in or imported into the United States, and (2) an occupational tax on marijuana production facilities and export warehouses. The term "marijuana product" does not include: (1) any article containing marijuana which has been approved by the Food and Drug Administration
(continued...)
Sponsored by: Sen. Ron Wyden
Read Twice And Referred To The Committee On Finance. on 03/30/2017
Spread the world
Gettr US Congress 115th Congress
Improving Access To Affordable Prescription Drugs Act [HB-1776]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Consumer Protection ]
[Public Health ]
[Funding ]
[Grants ]
[Taxes ]
Improving Access To Affordable Prescription Drugs Act This bill amends provisions of various laws relating to prescription-drug pricing and affordability. Specifically, the bill: expands reporting requirements for drug manufacturers and establishes corresponding civil penalties for noncompliance; adds reporting requirements for certain nonprofit patient-assistance programs; requires the Government Accountability Office (GAO) to report to Congress on the impact of patient-assistance programs on prescription-drug pricing and expenditures; requires
(continued...)
Sponsored by: Rep. Sean Maloney
Referred To The Subcommittee On Health. on 04/05/2017
Spread the world
US Congress 115th Congress
Improving Access To Affordable Prescription Drugs Act [S.771]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Consumer Protection ]
[Public Health ]
[Funding ]
[Grants ]
[Taxes ]
Improving Access To Affordable Prescription Drugs Act This bill amends provisions of various laws relating to prescription-drug pricing and affordability. Specifically, the bill: expands reporting requirements for drug manufacturers and establishes corresponding civil penalties for noncompliance; adds reporting requirements for certain nonprofit patient-assistance programs; requires the Government Accountability Office (GAO) to report to Congress on the impact of patient-assistance programs on prescription-drug pricing and expenditures; requires
(continued...)
Sponsored by: Sen. Jack Reed
Read Twice And Referred To The Committee On Finance. on 03/29/2017